Clinical Trial Update: Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B [Phase 1]

View source ↗

Summary

A Phase I safety and tolerability study of birinapant in chronic hepatitis B was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Birinapant

Snippet

Sponsor: TetraLogic Pharmaceuticals | Conditions: Hepatitis B | Phase 1 | Status: TERMINATED